Immunoregulation of Shenqi Fuzheng Injection Combined with Chemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis

Background. Immunosuppression is a well-recognised complication of chemotherapy in cancer patients. We assemble the clinical evidence that SQI, an adjuvant drug for lung cancer and gastric cancer which was widely prescribed in China, interventions could increase objective tumour response and regulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Ting, Wang, Xiao, Liu, Shufei, Fu, Wangxiao, Tan, Xiaoying, Wang, Xiumei, Gao, Boli, Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244024/
https://www.ncbi.nlm.nih.gov/pubmed/28154607
http://dx.doi.org/10.1155/2017/5121538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244024/
https://www.ncbi.nlm.nih.gov/pubmed/28154607
http://dx.doi.org/10.1155/2017/5121538

Ejemplares similares